Misplaced Pages

Lisinopril/hydrochlorothiazide

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by PotatoBot (talk | contribs) at 15:12, 10 September 2011 (Stub sorting and placement of stub template(s): cardiovascular-drug-stub. See approval. Report errors and suggestions at User talk:PotatoBot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 15:12, 10 September 2011 by PotatoBot (talk | contribs) (Stub sorting and placement of stub template(s): cardiovascular-drug-stub. See approval. Report errors and suggestions at User talk:PotatoBot.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Lisinopril/hydrochlorothiazide
Combination of
LisinoprilACE inhibitor
HydrochlorothiazideThiazide diuretic
Clinical data
MedlinePlusa601070
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
  (verify)

Lisinopril/hydrochlorothiazide (trade name Prinzide by Merck & Co., Zestoretic by AstraZeneca, and many others) is a combination of the drugs lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic. It is used to control hypertension.

References

Antihypertensive drugs acting on the renin–angiotensin system (C09)
ACE inhibitors
("-pril")
AIIRAs
("-sartan")
Renin inhibitors
("-kiren")
Dual ACE/NEP inhibitors
Neprilysin inhibitors
Other


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: